1. Home
  2. SRBK vs GNTA Comparison

SRBK vs GNTA Comparison

Compare SRBK & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SRBK

SR Bancorp Inc.

N/A

Current Price

$16.20

Market Cap

123.7M

Sector

N/A

ML Signal

N/A

Logo Genenta Science S.p.A.

GNTA

Genenta Science S.p.A.

HOLD

Current Price

$1.44

Market Cap

34.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRBK
GNTA
Founded
1887
2014
Country
United States
Italy
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
123.7M
34.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SRBK
GNTA
Price
$16.20
$1.44
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
36.6K
92.8K
Earning Date
01-30-2026
03-30-2026
Dividend Yield
1.23%
N/A
EPS Growth
374.69
N/A
EPS
0.54
N/A
Revenue
$31,130,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$29.90
N/A
Revenue Growth
0.85
N/A
52 Week Low
$11.36
$1.28
52 Week High
$17.11
$10.00

Technical Indicators

Market Signals
Indicator
SRBK
GNTA
Relative Strength Index (RSI) 55.61 36.07
Support Level $16.12 $1.28
Resistance Level $17.08 $1.68
Average True Range (ATR) 0.44 0.17
MACD -0.07 0.02
Stochastic Oscillator 47.64 27.42

Price Performance

Historical Comparison
SRBK
GNTA

About SRBK SR Bancorp Inc.

SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Share on Social Networks: